Self-Assembled Nanomicelles of Affibody-Drug Conjugate with Excellent Therapeutic Property to Cure Ovary and Breast Cancers
Abstract Affibody molecules are small non-immunoglobulin affinity proteins, which can precisely target to some cancer cells with specific overexpressed molecular signatures. However, the relatively short in vivo half-life of them seriously limited their application in drug targeted delivery for canc...
Main Authors: | Xuelin Xia, Xiaoyuan Yang, Wei Huang, Xiaoxia Xia, Deyue Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-12-01
|
Series: | Nano-Micro Letters |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40820-021-00762-9 |
Similar Items
-
PEG Linker Improves Antitumor Efficacy and Safety of Affibody-Based Drug Conjugates
by: Qiyu Li, et al.
Published: (2021-02-01) -
Incorporation of a Hydrophilic Spacer Reduces Hepatic Uptake of HER2-Targeting Affibody–DM1 Drug Conjugates
by: Haozhong Ding, et al.
Published: (2019-08-01) -
Recent Advances on Affibody- and DARPin-Conjugated Nanomaterials in Cancer Therapy
by: Federica Gabriele, et al.
Published: (2023-05-01) -
The Influence of Domain Permutations of an Albumin-Binding Domain-Fused HER2-Targeting Affibody-Based Drug Conjugate on Tumor Cell Proliferation and Therapy Efficacy
by: Wen Yin, et al.
Published: (2021-11-01) -
Affibody-Binding Ligands
by: Annalisa Barozzi, et al.
Published: (2020-05-01)